For first investigations regarding the suitability of microtissues as a therapeutic approach for bone regeneration, we added pre-differentiated microtissues (7 days in OM or OM+BMP-2) to a co-culture system of undifferentiated hMSC and PBMC [39,40]. This evidence concerns the gene BMP2 and ocular melanoma.